The Burden of Systemic Lupus Erythematosus in Germany: Incidence, Prevalence, and Healthcare Resource Utilization

The Economic Burden of Systemic Lupus Erythematosus in Commercially- and Medicaid-insured Populations in the United States

(2020) Ann E. Clarke et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Health Care Utilization and Costs of Systemic Lupus Erythematosus by Disease Severity in the United States

(2020) Irene B. Murimi et al.   JOURNAL OF RHEUMATOLOGY

2019 update of the EULAR recommendations for the management of systemic lupus erythematosus

(2019) Antonis Fanouriakis et al.   ANNALS OF THE RHEUMATIC DISEASES

Comparison of an administrative algorithm for SLE disease severity to clinical SLE Disease Activity Index scores

(2019) Cameron B. Speyer et al.   RHEUMATOLOGY INTERNATIONAL

Plan responses to diagnosis-based payment: Evidence from Germany’s morbidity-based risk adjustment

(2017) Sebastian Bauhoff et al.   JOURNAL OF HEALTH ECONOMICS

Introducing risk adjustment and free health plan choice in employer-based health insurance: Evidence from Germany

(2017) Adam Pilny et al.   JOURNAL OF HEALTH ECONOMICS

Statutory health insurance in Germany: a health system shaped by 135 years of solidarity, self-governance, and competition

(2017) Reinhard Busse et al.   LANCET

The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies

(2017) Frances Rees et al.   RHEUMATOLOGY

Clinical and financial burden of active lupus in Greece: a nationwide study

(2016) G Bertsias et al.   LUPUS

Quality of life and acquired organ damage are intimately related to activity limitations in patients with systemic lupus erythematosus

(2015) Mathilda Björk et al.   BMC MUSCULOSKELETAL DISORDERS

Costs Associated With Severe and Nonsevere Systemic Lupus Erythematosus in Canada

(2015) Ann E. Clarke et al.   ARTHRITIS CARE & RESEARCH

Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort

(2014) Ian N Bruce et al.   ANNALS OF THE RHEUMATIC DISEASES

Prevalence and incidence of systemic lupus erythematosus in France: A 2010 nation-wide population-based study

(2014) Laurent Arnaud et al.   AUTOIMMUNITY REVIEWS

Systemic lupus erythematosus

(2014) Larissa Lisnevskaia et al.   LANCET

Age-specific prevalence of diagnosed systemic lupus erythematosus in Germany 2002 and projection to 2030

(2014) R Brinks et al.   LUPUS

The cost of care of systemic lupus erythematosus (SLE) in the UK: annual direct costs for adult SLE patients with active autoantibody-positive disease

(2013) MA Khamashta et al.   LUPUS

Frequency of Computed Tomography Examinations in the Follow-Up Care of Testicular Cancer Patients - an Evaluation of Patterns of Care in Germany

(2013) Carsten Rusner et al.   ONKOLOGIE

Overall and Cause-Specific Mortality in Patients With Systemic Lupus Erythematosus: A Meta-Analysis of Observational Studies

(2013) Marko Yurkovich et al.   ARTHRITIS CARE & RESEARCH

Healthcare utilization and cost of systemic lupus erythematosus in a US managed care health plan

(2013) Cindy Garris et al.   JOURNAL OF MEDICAL ECONOMICS

Global Trend of Survival and Damage of Systemic Lupus Erythematosus: Meta-Analysis and Meta-Regression of Observational Studies from the 1950s to 2000s

(2012) Anselm Mak et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

(2011) Sandra V Navarra et al.   LANCET

Long-term medical costs and resource utilization in systemic lupus erythematosus and lupus nephritis: A five-year analysis of a large medicaid population

(2009) Tracy Li et al.   ARTHRITIS AND RHEUMATISM

Health care costs and costs associated with changes in work productivity among persons with systemic lupus erythematosus

(2008) Pantelis Panopalis et al.   ARTHRITIS AND RHEUMATISM